Farms.com Home   News

Vaccine innovation helps swine producers stay ahead of PCV2

Since emerging as a major pathogen 20 years ago, porcine circovirus type 2 (PCV2) has become a fact of life for swine producers. “Virtually every farm is infected,” says Dr. James “Jamie” Lehman, DVM, MS, swine technical services veterinarian for Merck Animal Health. “It’s just a challenge of managing your immunity both in the sow herd and among your piglets.”

A large part of Dr. Lehman’s job is working with producers and veterinarians to troubleshoot PCV2 health problems. He sees pigs with PCV2 infections exhibiting poor growth rates, lethargy and skin lesions.1 Understanding the dynamics of each herd helps Merck Animal Health recommend PCV2 vaccine protocols that create the most positive outcome.

“We support customers with diagnostic plans and herd visits as needed, getting to know the operation and help plan the investigation.” Dr. Lehman says. “Every case is different, depending on the age of pig affected.”

Click here to see more...

Trending Video

Inside the Battle Against Streptococcus suis - Dr. Mariela Segura

Video: Inside the Battle Against Streptococcus suis - Dr. Mariela Segura

In this special rerun episode of The Swine it Podcast Show Canada, Dr. Mariela Segura from the University of Montreal explains the current challenges and future perspectives of Streptococcus suis vaccines. She discusses the impact of the pathogen on pig health, antibiotic resistance, zoonotic risks, and the latest vaccine innovations. Gain insights into how the swine industry can improve disease control. Listen now on all major platforms! "Streptococcus suis is not only a major economic concern in the swine industry but also a zoonotic pathogen." Meet the guest: Dr. Mariela Segura / mariela-segura-442a8425a is a full professor at the Faculty of Veterinary Medicine at the University of Montreal and the director of the Swine and Poultry Infectious Diseases Center (CRIPA). She earned her master's and Ph.D. from the Université de Montréal.